DMK Group appoints COO for Baby Food business unit

By Jim Cornall contact

- Last updated on GMT

Dr Marc-Alexander Mahl takes up his new position in January 2021. Pic: DMK
Dr Marc-Alexander Mahl takes up his new position in January 2021. Pic: DMK

Related tags: Dmk, Infant formula

German dairy cooperative DMK Group has announced a change in management for its baby food business area.

Dr Marc-Alexander Mahl, 52, will take on the position of chief operating officer from January 1, 2021.  

Mahl follows Stefan Eckert, who left the company at the end of 2019. CEO Ingo Müller has been responsible for the unit on an interim basis. Mahl comes from Fresenius Kabi, a company active in the fields of clinical nutrition, infusion therapy, generic drugs and medicinal products. He has been heading up the business unit generics & complex formulations as executive vice president since 2011.

Müller said, “We are pleased to have gained Marc Mahl as a highly experienced manager for this position. His experience will allow him to drive forward the Baby Food business unit. I have come to know Marc Mahl as a positive person with the ability to win people over and inspire them in global teams. He comes to us with the clear remit of ensuring – together with the team –that the Baby Food business area from the Baby business unit will make a successful contribution to the DMK Group result.

“And we’re going to pick up the pace here: through a broad campaign involving various measures, we want and have to create a foundation for generating added value in the Baby Food area in the future. The basis for being able to achieve these ambitious goals is an effective team.”

Mahl said, “Comparatively, the baby food sector is one of the most attractive consumer goods markets worldwide. In the DMK Group’s mission statement for 2030, the Baby BU takes on an important role in growth – the tasks that await me there will allow me to draw on my many years of experience and use it in a new and exciting work environment​.”



Related topics: Manufacturers, Nutritionals


Post your comment

We will not publish your email address on the website

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.

Follow us


View more